Corbus Pharmaceuticals Holdings, Inc. (CRBP) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 97.32K | 136.56K |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -100% | -100% | -100% | -100% | -92.09% | -52.31% |
| Cost of Goods Sold | 49K | 0 | 0 | 100K | 15.64M | 146K | 0 | 200K | 0 | 147.98K | 0 | 0 | 0 | 0 | 374.8K | 370.38K | 368.45K | 375.15K | 8.32M | 11.27M |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8544.37% | 8249.4% |
| Gross Profit | -49K | 0 | 0 | -100K | -15.64M | -146K | 0 | -200K | 0 | -147.98K | 0 | 0 | 0 | 0 | -374.8K | -370.38K | -368.45K | -375.15K | -8.22M | -11.13M |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -8444.37% | -8149.4% |
| Gross Profit Growth % | 99.69% | 100% | - | 50% | - | 1.34% | - | - | - | - | 100% | 100% | 100% | 100% | 95.44% | 96.67% | 96.34% | 97.57% | 68.74% | -3986.44% |
| Operating Expenses | 24.25M | 21.97M | 24.42M | 19.05M | 4.13M | 12.46M | 15.51M | 10.79M | 9.62M | 9.96M | 9.49M | 8.19M | 17.3M | 10.8M | 7.81M | 6.97M | 8.15M | 9.62M | 5.66M | 5.57M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5812.7% | 4080.61% |
| Selling, General & Admin | 4.44M | 3.56M | 3.56M | 3.96M | 4.13M | 3.67M | 4.7M | 3.92M | 3.86M | 2.98M | 2.94M | 3.94M | 3.91M | 4.55M | 3.7M | 4.47M | 4.86M | 3.86M | 5.05M | 5.57M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5190.03% | 4080.61% |
| Research & Development | 19.82M | 18.41M | 20.86M | 15.19M | 15.64M | 8.79M | 10.81M | 6.87M | 5.76M | 6.98M | 6.55M | 4.25M | 13.39M | 6.24M | 4.11M | 2.5M | 3.29M | 5.76M | 8.7M | 11.27M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8934.83% | 8249.4% |
| Other Operating Expenses | 0 | 0 | 0 | -100K | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1000K | -1000K |
| Operating Income | -24.3M | -21.97M | -24.42M | -19.15M | -19.77M | -12.61M | -15.51M | -10.99M | -9.62M | -10.1M | -9.49M | -8.19M | -17.3M | -10.8M | -8.18M | -7.34M | -8.52M | -10M | -13.88M | -16.7M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -14257.07% | -12230.01% |
| Operating Income Growth % | -22.9% | -74.26% | -57.48% | -74.3% | -105.5% | -24.76% | -63.42% | -34.18% | 44.37% | 6.42% | -15.97% | -11.57% | -103.08% | -7.99% | 41.04% | 56.05% | 44.74% | 51.96% | 59.16% | 56.21% |
| EBITDA | -24.3M | -21.92M | -24.37M | -19.05M | -19.69M | -12.46M | -15.35M | -10.79M | -9.47M | -9.96M | -9.34M | -8.03M | -17.12M | -10.42M | -7.81M | -6.97M | -8.15M | -9.62M | -13.62M | -16.44M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -13993.73% | -12036.94% |
| EBITDA Growth % | -23.41% | -75.91% | -58.71% | -76.6% | -107.94% | -25.15% | -64.47% | -34.33% | 44.66% | 4.48% | -19.58% | -15.23% | -110.04% | -8.31% | 42.68% | 57.6% | 46.18% | 53.13% | 59.67% | 56.37% |
| D&A (Non-Cash Add-back) | 0 | 49K | 50K | 100K | 81K | 146K | 152K | 200K | 152K | 147.98K | 153K | 158.13K | 181.87K | 374.22K | 374.8K | 370.38K | 368.45K | 375.15K | 256.29K | 263.66K |
| EBIT | -24.3M | -20.55M | -23.34M | -17.66M | -18.66M | -9.53M | -13.4M | -9.35M | -6.06M | -7.31M | -9.07M | -7.78M | -17.3M | -10.8M | -8.24M | -12.76M | -8.98M | -9.87M | -13.27M | -16.7M |
| Net Interest Income | 1.4M | 1.41M | 1.13M | 1.31M | 1.68M | 3.55M | 808K | 254K | -177.01K | -707.01K | -763.36K | -776K | -678.02K | -640.95K | -541.89K | -490.34K | -458.91K | -390.9K | -391.87K | -401.17K |
| Interest Income | 1.4M | 1.41M | 1.13M | 1.31M | 1.68M | 3.55M | 1.19M | 906K | 0 | 0 | 0 | 232K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 381K | 652K | 177.01K | 707.01K | 763.36K | 1.01M | 678.02K | 640.95K | 541.89K | 490.34K | 458.91K | 390.9K | 391.87K | 401.17K |
| Other Income/Expense | 1.33M | 1.41M | 1.07M | 1.49M | 2.8M | 3.08M | 1.72M | 991K | 2.72M | 2.08M | -565K | -595K | -447.79K | -82.23K | -600.26K | -5.91M | -920.08K | -262.37K | 11.7M | -437.32K |
| Pretax Income | -22.97M | -20.55M | -23.34M | -17.66M | -16.98M | -9.53M | -13.78M | -10M | -6.9M | -8.02M | -10.05M | -8.78M | -17.74M | -10.88M | -8.78M | -13.25M | -9.44M | -10.26M | -2.18M | -17.14M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2236.01% | -12550.25% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -22.97M | -20.55M | -23.34M | -17.66M | -16.98M | -9.53M | -13.78M | -10M | -6.9M | -8.02M | -10.05M | -8.78M | -17.74M | -10.88M | -8.78M | -13.25M | -9.44M | -10.26M | -2.18M | -17.14M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2236.01% | -12550.25% |
| Net Income Growth % | -35.29% | -115.69% | -69.35% | -76.67% | -146.09% | -18.81% | -37.1% | -13.81% | 61.12% | 26.27% | -14.48% | 33.7% | -88.03% | -6.03% | -303.54% | 22.69% | 41.26% | -19.15% | 93.76% | 55.02% |
| Net Income (Continuing) | -22.97M | -20.55M | -23.34M | -17.66M | -16.98M | -9.53M | -13.78M | -10M | -6.9M | -8.02M | -10.05M | -8.78M | -17.74M | -10.88M | -8.78M | -13.25M | -9.44M | -10.26M | -2.18M | -17.14M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.72 | -1.54 | -1.90 | -1.44 | -1.39 | -0.78 | -1.15 | -3.55 | -2.45 | -1.81 | -2.27 | -2.05 | -4.24 | -2.61 | -2.10 | -3.17 | -2.26 | -2.46 | -0.52 | -4.42 |
| EPS Growth % | -23.74% | -97.44% | -65.22% | 59.44% | 43.27% | 56.91% | 49.34% | -73.17% | 42.22% | 30.65% | -8.1% | 35.33% | -87.61% | -6.1% | -303.85% | 28.28% | 45.41% | 16.89% | 95.93% | 71.43% |
| EPS (Basic) | -1.72 | -1.54 | -1.90 | -1.44 | -1.39 | -0.78 | -1.15 | -3.55 | -2.45 | -1.81 | -2.27 | -2.05 | -4.24 | -2.61 | -2.11 | -3.18 | -2.26 | -2.46 | -0.52 | -4.42 |
| Diluted Shares Outstanding | 13.32M | 13.32M | 12.31M | 12.24M | 12.2M | 12.18M | 12.01M | 2.81M | 2.81M | 4.42M | 4.42M | 4.28M | 4.18M | 4.17M | 4.18M | 4.18M | 4.17M | 4.17M | 4.17M | 3.88M |
| Basic Shares Outstanding | 13.32M | 13.32M | 12.31M | 12.24M | 12.2M | 12.18M | 12.01M | 2.81M | 2.81M | 4.42M | 4.42M | 4.28M | 4.18M | 4.17M | 4.17M | 4.17M | 4.17M | 4.17M | 4.17M | 3.88M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |